RESTRICTIONS AND CONSENTS. There are no agreements, Laws or other restrictions of any kind to which such Stockholder is party or subject that would prevent or restrict the execution, delivery or performance of this Agreement by such Stockholder.
RESTRICTIONS AND CONSENTS. Such Principal Stockholder's execution and delivery of this Agreement and the Related Agreements does not, and such Principal Stockholder's performance of this Agreement and the Related Agreements will not, require any consent, approval, authorization or permit of, or filing with or notification to, any third party or any court, arbitral tribunal, regulatory body, administrative agency or commission or Government Entity, except for the filing and recordation of appropriate merger documents as required by the CGCL and the DGCL and applicable state and federal securities related filings.
RESTRICTIONS AND CONSENTS. Except as set forth on the Disclosure Schedule, there are no Agreements, Laws or other restrictions of any kind to which the Company is a party or to which the Company's Assets are subject that would prevent or restrict the execution, delivery or performance of this Purchase Agreement or prohibit or limit the continued operation of the business of the Company after the date hereof on substantially the same basis as heretofore operated, as a result of the execution, delivery or performance of this Purchase Agreement. The Disclosure Schedule lists all Agreements and Laws that require the consent or acquiescence of any person or entity not party to this Purchase Agreement with respect to any aspect of the execution, delivery or performance of this Purchase Agreement by the Company.
RESTRICTIONS AND CONSENTS. There are no Agreements, Laws or other restrictions of any kind to which the Company, any Subsidiary or any Medical Group (or any asset thereof) is party or subject that would prevent or restrict the execution, delivery or performance of the Option Agreement or result in any penalty, forfeiture, Agreement termination, or restriction on business operations of the Investor, the Company, any Subsidiary or any Medical Group as a result of the execution, delivery or performance of the Option Agreement. Schedule 3 lists all such Agreements and Laws that reasonably could be interpreted or expected to require the consent or acquiescence of any person or entity not party to the Option Agreement with respect to any aspect of the execution, delivery or performance of the Option Agreement by the Company, any Subsidiary or any Medical Group.
RESTRICTIONS AND CONSENTS. There are no agreements, Laws or other restrictions of any kind to which OASIS is party or subject that would prevent or restrict the execution, delivery or performance of this Agreement by OASIS.
RESTRICTIONS AND CONSENTS. Except as set forth in the Disclosure Schedule, there are no Agreements, Laws or other restrictions to which the Company is a party or subject that would prevent or restrict the execution, delivery or performance of this Purchase Agreement by the Company or result in any penalty, forfeiture, Agreement termination, or restriction on business operations of the Company as a result of the execution, delivery or performance of this Purchase Agreement by the Company. The Disclosure Schedule lists all such Agreements and Laws that require the consent or acquiescence of any person or entity not party to this Purchase Agreement with respect to any aspect of the execution, delivery or performance of this Purchase Agreement by the Company.
RESTRICTIONS AND CONSENTS. There are no Agreements, Laws or other restrictions of any kind to which HeadHunter is party or subject that would prevent or restrict the execution, delivery or performance of this Investment Agreement or result in any penalty, forfeiture, Agreement termination, or restriction on business operations of the LLC, ITC or HeadHunter as a result of the execution, delivery or performance of this Investment Agreement. The Disclosure Schedule lists all such Agreements and Laws that reasonably could be interpreted or expected to require the consent or acquiescence of any person or entity not party to this Investment Agreement with respect to any aspect of the execution, delivery or performance of this Investment Agreement by HeadHunter and the Shareholder.
RESTRICTIONS AND CONSENTS. This lease shall be and is subject to all the terms, covenants, restrictions, reservations and agreements contained in Quit Claim Deed dated December 21, 1966, by the United States of America, to the Port of xxxxxx, recorded in Benton County, Washington on April 26, 1972, in Volume 1of Deeds, under Auditor’s File No. 633654, records of said County, including the written consent of the Federal Aviation Agency if the leased premises are to be used for other than airport purposes. This lease is also subject to the most current and any future federal grant obligations, Airport rules and regulations, Airport Minimum Standards and policies’, including the written consent of the Federal Aviation Agency if the leased premises are to be used for other than airport purposes. This lease is also subject to the most current and any future federal grant obligations, Airport rules and regulations, Airport Minimum Standards and policies.
RESTRICTIONS AND CONSENTS. There are no Agreements, Laws or other restrictions of any kind to which the Stockholder is party or subject that would prevent or restrict the execution, delivery or performance of this Agreement or result in any penalty, forfeiture, Agreement termination, or restriction on business operations of Purchaser or the Company as a result of the execution, delivery or performance of this Agreement. Schedule 5.4 lists all such Agreements and Laws that reasonably could be interpreted or expected to require the consent or acquiescence of any person or entity not party to this Agreement with respect to any aspect of the execution, delivery or performance of this Agreement by the Company.
RESTRICTIONS AND CONSENTS. 16 3.24. Authorization.................................................16 3.25. Absence of Violations.........................................17 3.26. Regulatory Matters............................................17
